Skip to main content

Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of salmonella enteric fever

Infection volume 17, pages 105–106 (1989)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Wise, R., Andrews, J. M., Edwards, L. J. In vitro activity of Bay 9867, a new quinolone derivative, compared with those of other antimicrobial agents. Antimicrob. Agents Chemother. 23 (1983) 569–574.

    Google Scholar 

  2. Fass, R. J. In vitro activity of ciprofloxacin (Bay 9867). Antimicrob. Agents Chemother. 24 (1983) 568–573.

    Google Scholar 

  3. Schacht, P., Deck, K., Arieri, G., Ryoki, T. Overview of international clinical studies of ciprofloxacin, with special reference to safety. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 435–445.

    Google Scholar 

  4. Limson, B. M. Efficacy and safety of ciprofloxacin in uncomplicated typhoid fever. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 362–364.

    Google Scholar 

  5. Ramirez, C. A., Bran, J. L., Mejica, C. R., Garcia, J. F. Clinical efficacy of ciprofloxacin in typhoid fever. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, pp. 365–369.

    Google Scholar 

  6. Eykyn, S. J., Williams, H. Treatment of multiresistantSalmonella typhi with oral ciprofloxacin. Lancet II (1987) 1407–1408.

    Google Scholar 

  7. Diride, G., Pichler, H., Wolf, D. Four-week treatment of chronicSalmonella carriers with ciprofloxacin and its influence on faecal flora. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, p. 370.

    Google Scholar 

  8. Heise-Reinecker, E., Ruschmeyer, J., Rosenfeld, M. Clinical efficacy of ciprofloxacin inSalmonella carriers. In:Neu, H. C., Weuta, H. (eds.): 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Medica, Amsterdam, 1986, p. 373.

    Google Scholar 

  9. Hudson, S. J., Ingham, H. R., Snow, M. R. Treatment ofSalmonella typhi carrier state with ciprofloxacin. Lancet I (1985) 1047.

    Google Scholar 

  10. Overtune, G., Marton, K. I., Mathies, A. W. Antibiotic resistance in typhoid fever. N. Eng. J. Med. 289 (1973) 463–465.

    Google Scholar 

  11. Olarte, J., Galindo, E.: Salmonella typhi resistant to chloramphenicol, ampicillin and other antimicrobial agents. Antimicrob. Agents Chemother. (1973) 597–601.

Download references

Author information

Affiliations

  1. Microbiology Section, Makati Medical Center, Makati, Manila, Philippines

    B. M. Limson &  R. T. Littaua

Authors
  1. B. M. Limson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. T. Littaua
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Limson, B.M., Littaua, R.T. Comparative study of ciprofloxacin versus co-trimoxazole in the treatment of salmonella enteric fever. Infection 17, 105–106 (1989). https://doi.org/10.1007/BF01646892

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01646892

Keywords

  • Public Health
  • Internal Medicine
  • Infectious Disease
  • General Practice
  • Family Medicine